COPD patients’ perspectives should guide development of new therapies

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into the development process of new therapies for COPD, according to a new commentary.

Royalty Pharma inks MS deal with ImmuNext; X4 sells its priority review voucher

Plus, news about Pacira Biosciences, Cassava Sciences, Merck, Monopar Therapeutics, Eli Lilly and Optinose: Royalty Pharma signs MS deal: The company will pay about $525

May 10, 2024

Tim Walz stood up to corporate health care. Mayo Clinic was a powerful exception

MINNEAPOLIS — Even for the most progressive of politicians, money talks. And elite nonprofit hospitals can throw around a lot of money. Minnesota Gov. Tim

August 6, 2024

NABP, IBM Partner to Build Platform to Protect Drug Supply Chain

What You Should Know: The National Association of Boards of Pharmacy® (NABP®) and IBM Consulting are pleased to announce their collaboration to build Pulse by NABP™, a new

July 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.